1	Comparison	comparison	NN	NN	_	0	ROOT	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	laboratory	laboratory	NN	NN	_	4	nn	_	_
4	costs	cost	NNS	NNS	_	2	pobj	_	_
5	of	of	IN	IN	_	4	prep	_	_
6	rapid	rapid	JJ	JJ	_	8	amod	_	_
7	molecular	molecular	JJ	JJ	_	8	amod	_	_
8	tests	test	NNS	NNS	_	5	pobj	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	conventional	conventional	JJ	JJ	_	11	amod	_	_
11	diagnostics	diagnostic	NNS	NNS	_	8	conj	_	_
12	for	for	IN	IN	_	1	prep	_	_
13	detection	detection	NN	NN	_	12	pobj	_	_
14	of	of	IN	IN	_	13	prep	_	_
15	tuberculosis	tuberculosis	NN	NN	_	14	pobj	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	drug-resistant	drug-resistant	JJ	JJ	_	18	amod	_	_
18	tuberculosis	tuberculosis	NN	NN	_	15	conj	_	_
19	in	in	IN	IN	_	13	prep	_	_
20	South	South	NNP	NNP	_	21	nn	_	_
21	Africa	Africa	NNP	NNP	_	19	pobj	_	_
22	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	World	World	NNP	NNP	_	4	nn	_	_
3	Health	Health	NNP	NNP	_	4	nn	_	_
4	Organization	Organization	NNP	NNP	_	6	nsubj	_	_
5	has	have	VBZ	VBZ	_	6	aux	_	_
6	endorsed	endorse	VBN	VBN	_	0	ROOT	_	_
7	the	the	DT	DT	_	8	det	_	_
8	use	use	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	molecular	molecular	JJ	JJ	_	11	amod	_	_
11	methods	method	NNS	NNS	_	9	pobj	_	_
12	for	for	IN	IN	_	8	prep	_	_
13	the	the	DT	DT	_	14	det	_	_
14	detection	detection	NN	NN	_	12	pobj	_	_
15	of	of	IN	IN	_	14	prep	_	_
16	TB	tb	NN	NN	_	15	pobj	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	drug-resistant	drug-resistant	JJ	JJ	_	19	amod	_	_
19	TB	tb	NN	NN	_	16	conj	_	_
20	as	as	IN	IN	_	6	prep	_	_
21	a	a	DT	DT	_	23	det	_	_
22	rapid	rapid	JJ	JJ	_	23	amod	_	_
23	alternative	alternative	NN	NN	_	20	pobj	_	_
24	to	to	TO	TO	_	23	prep	_	_
25	culture-based	culture-based	JJ	JJ	_	26	amod	_	_
26	systems	system	NNS	NNS	_	24	pobj	_	_
27	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	15	prep	_	_
2	South	South	NNP	NNP	_	3	nn	_	_
3	Africa	Africa	NNP	NNP	_	1	pobj	_	_
4	,	,	,	,	_	15	punct	_	_
5	the	the	DT	DT	_	8	det	_	_
6	Xpert	Xpert	NNP	NNP	_	8	nn	_	_
7	MTB/Rif	mtb/rif	NN	NN	_	8	nn	_	_
8	assay	assay	NN	NN	_	15	nsubjpass	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	the	the	DT	DT	_	12	det	_	_
11	GenoType	genotype	NN	NN	_	12	nn	_	_
12	MTBDRplus	mtbdrplus	NN	NN	_	8	conj	_	_
13	have	have	VBP	VBP	_	15	aux	_	_
14	been	be	VBN	VBN	_	15	auxpass	_	_
15	implemented	implement	VBN	VBN	_	0	ROOT	_	_
16	into	into	IN	IN	_	15	prep	_	_
17	reference	reference	NN	NN	_	18	nn	_	_
18	laboratories	laboratory	NNS	NNS	_	16	pobj	_	_
19	for	for	IN	IN	_	15	prep	_	_
20	diagnosis	diagnosis	NN	NN	_	19	pobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	TB	tb	NN	NN	_	21	pobj	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	drug-resistance	drug-resistance	NN	NN	_	22	conj	_	_
25	,	,	,	,	_	15	punct	_	_
26	but	but	CC	CC	_	15	cc	_	_
27	their	they	PRP$	PRP$	_	28	poss	_	_
28	costs	cost	NNS	NNS	_	33	nsubjpass	_	_
29	have	have	VBP	VBP	_	33	aux	_	_
30	not	not	RB	RB	_	33	neg	_	_
31	been	be	VBN	VBN	_	33	auxpass	_	_
32	fully	fully	RB	RB	_	33	advmod	_	_
33	elucidated	elucidate	VBN	VBN	_	15	conj	_	_
34	.	.	.	.	_	15	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	conducted	conduct	VBD	VBD	_	0	ROOT	_	_
3	a	a	DT	DT	_	8	det	_	_
4	detailed	detailed	JJ	JJ	_	8	amod	_	_
5	reference	reference	NN	NN	_	8	nn	_	_
6	laboratory	laboratory	NN	NN	_	8	nn	_	_
7	cost	cost	NN	NN	_	8	nn	_	_
8	analysis	analysis	NN	NN	_	2	dobj	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	new	new	JJ	JJ	_	13	amod	_	_
11	rapid	rapid	JJ	JJ	_	13	amod	_	_
12	molecular	molecular	JJ	JJ	_	13	amod	_	_
13	assays	assay	NNS	NNS	_	9	pobj	_	_
14	-LRB-	-lrb-	-LRB-	-LRB-	_	15	punct	_	_
15	Xpert	xpert	NN	NN	_	13	dep	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	MTBDRplus	mtbdrplus	NN	NN	_	15	conj	_	_
18	-RRB-	-rrb-	-RRB-	-RRB-	_	15	punct	_	_
19	for	for	IN	IN	_	8	prep	_	_
20	tuberculosis	tuberculosis	NN	NN	_	21	nn	_	_
21	testing	testing	NN	NN	_	19	pobj	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	drug-resistance	drug-resistance	JJ	JJ	_	24	amod	_	_
24	testing	testing	NN	NN	_	21	conj	_	_
25	in	in	IN	IN	_	21	prep	_	_
26	South	South	NNP	NNP	_	27	nn	_	_
27	Africa	Africa	NNP	NNP	_	25	pobj	_	_
28	,	,	,	,	_	2	punct	_	_
29	and	and	CC	CC	_	2	cc	_	_
30	compared	compare	VBN	VBN	_	2	conj	_	_
31	with	with	IN	IN	_	30	pcomp	_	_
32	the	the	DT	DT	_	33	det	_	_
33	costs	cost	NNS	NNS	_	31	pobj	_	_
34	of	of	IN	IN	_	33	prep	_	_
35	conventional	conventional	JJ	JJ	_	36	amod	_	_
36	approaches	approach	NNS	NNS	_	34	pobj	_	_
37	involving	involve	VBG	VBG	_	36	vmod	_	_
38	sputum	sputum	NN	NN	_	39	nn	_	_
39	microscopy	microscopy	NN	NN	_	37	dobj	_	_
40	,	,	,	,	_	39	punct	_	_
41	liquid	liquid	JJ	JJ	_	43	amod	_	_
42	mycobacterial	mycobacterial	JJ	JJ	_	43	amod	_	_
43	culture	culture	NN	NN	_	39	conj	_	_
44	,	,	,	,	_	39	punct	_	_
45	and	and	CC	CC	_	39	cc	_	_
46	phenotypic	phenotypic	JJ	JJ	_	49	amod	_	_
47	drug	drug	NN	NN	_	49	nn	_	_
48	sensitivity	sensitivity	NN	NN	_	49	nn	_	_
49	testing	testing	NN	NN	_	39	conj	_	_
50	.	.	.	.	_	2	punct	_	_

1	From	from	IN	IN	_	8	prep	_	_
2	a	a	DT	DT	_	4	det	_	_
3	laboratory	laboratory	NN	NN	_	4	nn	_	_
4	perspective	perspective	NN	NN	_	1	pobj	_	_
5	,	,	,	,	_	8	punct	_	_
6	Xpert	Xpert	NNP	NNP	_	7	nn	_	_
7	MTB/RIF	MTB/RIF	NNP	NNP	_	8	nsubj	_	_
8	cost	cost	VBD	VBD	_	0	ROOT	_	_
9	$	$	$	$	_	8	dobj	_	_
10	14.93	14.93	CD	CD	_	9	num	_	_
11	/	/	:	:	_	8	punct	_	_
12	sample	sample	NN	NN	_	8	dep	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	the	the	DT	DT	_	18	det	_	_
15	MTBDRplus	mtbdrplus	NN	NN	_	18	nn	_	_
16	line	line	NN	NN	_	18	nn	_	_
17	probe	probe	NN	NN	_	18	nn	_	_
18	assay	assay	NN	NN	_	12	conj	_	_
19	cost	cost	VBD	VBD	_	8	parataxis	_	_
20	$	$	$	$	_	19	dobj	_	_
21	23.46	23.46	CD	CD	_	20	num	_	_
22	/	/	:	:	_	19	punct	_	_
23	sample	sample	NN	NN	_	19	dep	_	_
24	,	,	,	,	_	19	punct	_	_
25	compared	compare	VBN	VBN	_	19	prep	_	_
26	to	to	TO	TO	_	25	pcomp	_	_
27	$	$	$	$	_	26	pobj	_	_
28	16.88	16.88	CD	CD	_	27	num	_	_
29	/	/	:	:	_	19	punct	_	_
30	sample	sample	NN	NN	_	19	dobj	_	_
31	using	use	VBG	VBG	_	30	vmod	_	_
32	conventional	conventional	JJ	JJ	_	36	amod	_	_
33	automated	automate	VBN	VBN	_	36	amod	_	_
34	liquid	liquid	JJ	JJ	_	36	amod	_	_
35	culture-based	culture-based	JJ	JJ	_	36	amod	_	_
36	methods	method	NNS	NNS	_	31	dobj	_	_
37	.	.	.	.	_	8	punct	_	_

1	Laboratory	laboratory	NN	NN	_	2	nn	_	_
2	costs	cost	NNS	NNS	_	9	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	Xpert	Xpert	NNP	NNP	_	3	pobj	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	MTBDRplus	mtbdrplus	NN	NN	_	4	conj	_	_
7	were	be	VBD	VBD	_	9	auxpass	_	_
8	most	most	RBS	RBS	_	9	advmod	_	_
9	influenced	influence	VBN	VBN	_	0	ROOT	_	_
10	by	by	IN	IN	_	9	prep	_	_
11	cost	cost	NN	NN	_	10	pobj	_	_
12	of	of	IN	IN	_	11	prep	_	_
13	consumables	consumable	NNS	NNS	_	12	pobj	_	_
14	-LRB-	-lrb-	-LRB-	-LRB-	_	16	punct	_	_
15	60-80	60-80	CD	CD	_	16	num	_	_
16	%	%	NN	NN	_	13	appos	_	_
17	-RRB-	-rrb-	-RRB-	-RRB-	_	16	punct	_	_
18	.	.	.	.	_	9	punct	_	_

1	At	at	IN	IN	_	12	prep	_	_
2	current	current	JJ	JJ	_	5	amod	_	_
3	public	public	JJ	JJ	_	5	amod	_	_
4	sector	sector	NN	NN	_	5	nn	_	_
5	pricing	pricing	NN	NN	_	1	pobj	_	_
6	,	,	,	,	_	12	punct	_	_
7	Xpert	Xpert	NNP	NNP	_	8	nn	_	_
8	MTB/RIF	mtb/rif	NN	NN	_	12	nsubj	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	MTBDRplus	mtbdrplus	NN	NN	_	8	conj	_	_
11	are	be	VBP	VBP	_	12	cop	_	_
12	comparable	comparable	JJ	JJ	_	0	ROOT	_	_
13	in	in	IN	IN	_	12	prep	_	_
14	cost	cost	NN	NN	_	13	pobj	_	_
15	to	to	TO	TO	_	14	prep	_	_
16	mycobacterial	mycobacterial	JJ	JJ	_	17	amod	_	_
17	culture	culture	NN	NN	_	15	pobj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	conventional	conventional	JJ	JJ	_	22	amod	_	_
20	drug	drug	NN	NN	_	22	nn	_	_
21	sensitivity	sensitivity	NN	NN	_	22	nn	_	_
22	testing	testing	NN	NN	_	17	conj	_	_
23	.	.	.	.	_	12	punct	_	_

1	Overall	overall	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	reference	reference	NN	NN	_	4	nn	_	_
4	laboratories	laboratory	NNS	NNS	_	6	nsubj	_	_
5	must	must	MD	MD	_	6	aux	_	_
6	balance	balance	VB	VB	_	0	ROOT	_	_
7	costs	cost	NNS	NNS	_	6	dobj	_	_
8	with	with	IN	IN	_	6	prep	_	_
9	performance	performance	NN	NN	_	10	nn	_	_
10	characteristics	characteristic	NNS	NNS	_	8	pobj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	the	the	DT	DT	_	13	det	_	_
13	need	need	NN	NN	_	10	conj	_	_
14	for	for	IN	IN	_	13	prep	_	_
15	rapid	rapid	JJ	JJ	_	16	amod	_	_
16	results	result	NNS	NNS	_	14	pobj	_	_
17	.	.	.	.	_	6	punct	_	_
